Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

VirtualScopics entered into a scientific collaboration, specific to molecular imaging, with ABX-CRO, a Dresden, Germany based full-service contract research organization.

VirtualScopics , Inc., a leading provider of quantitative imaging for clinical trials, announced it has entered into a scientific collaboration, specific to molecular imaging, with ABX-CRO, a Dresden, Germany based full-service contract research organization. The collaboration joins two of the scientific pioneers in the use of advanced imaging for the clinical study of drugs and medical devices.

This partnership will provide pharmaceutical customers with an integrated service offering by leveraging the combined knowledge and experience of both VirtualScopics and ABX-CRO in the area of functional imaging, especially, Positron Emission Tomography ( PET ), Single Photon Emission Computed Tomography ( SPECT ) and Magnetic Resonance Imaging ( MRI ). The companies' complementary expertise in imaging analysis and administration of radiopharmaceuticals offers turn-key solutions to customers seeking to capitalize on molecular imaging's ability to quantitatively assess pharmacokinetics and metabolism.

"This collaboration of two of the leaders in the use of molecular imaging in clinical trials will allow each company's customers to source best in class service offerings on a global basis," said VirtualScopics President and Chief Executive Officer, Jeff Markin. He continued, "The coupling of VirtualScopics' robust image acquisition and analysis package with ABX-CRO's expertise with new and evolving tracers will provide a unique and unparalleled solution with regard to the use of functional imaging in drug and medical device development."

VirtualScopics and ABX-CRO will be on site September 8 and 9 at the World Molecular Imaging Congress in Kyoto, Japan at booth # 421 to discuss further details of the companies' applications and their benefit to sponsors of clinical trials, and to present ABX-DIRECT.

Source: VirtualScopics , Inc.